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InvasionOne criterion for microRNA identiﬁcation is based on their conservation across species, and prediction of miRNA
targets by empirical approaches using computational analysis relies on the presence of conservative mRNA 3′
UTR. Because most miRNA target sites identiﬁed are highly conserved across different species, it is not clear
whether miRNA targeting is species-speciﬁc. To predict miRNA targeting, we aligned all available ﬁbronectin 3′
UTRs and observed signiﬁcant conservation of all 20 species. TwelvemiRNAswere predicted to targetmostﬁbro-
nectin 3′UTRs, but rodent ﬁbronectin showed potential binding sites speciﬁc for ﬁve different miRNAs. One of
them, the miR-378a-5p, contained a complete matching seed-region for all rodent ﬁbronectin, which could not
be found in any other species. We designed experiments to test whether the species-speciﬁc targeting possessed
biological function and found that expression of miR-378a-5p decreased cancer cell proliferation, migration, and
invasion, resulting in inhibition of tumor growth. Silencing ﬁbronectin expression produced similar effects as
miR-378a-5p, while transfection with a construct targeting miR-378-5p produced opposite results. Tumor for-
mation assay showed that enhanced expression of ﬁbronectin in the stromal tissues as a background environ-
ment suppressed tumor growth, while increased ﬁbronectin expression inside the tumor cells promoted
tumor growth. This was likely due to the different signaling direction, either inside-out or outside-in signal.
Our results demonstrated that species-speciﬁc targeting by miRNA could also exert functional effects. Thus,
one layer of regulation has been added to the complex network of miRNA signaling.
© 2013 Published by Elsevier B.V.1. Introduction
MicroRNAs (miRNAs) are a group of non-coding RNA of approxi-
mately 21 nucleotides in length. Most miRNA loci are found in the
non-coding intronic regions, whereas some are located in exonic re-
gions [1–4]. Similar to other types of genes, miRNA genes are driven
by promoters and are transcribed into primary miRNAs (pri-miRNAs)
by RNA polymerase II. The transcripts are then processed by Drosha to
release hairpin intermediate precursor miRNAs (pre-miRNAs), which
could be in sizes of 70–110 nucleotides, and mature miRNAs. The ma-
ture miRNAs can regulate gene expression by targeting mRNAs post-
transcriptionally. Extensive literature has reported that miRNAs playedium; FBS, fetal bovine serum;
NA; miRNA, microRNA; 3′-UTR,
ersity Town, Shenzhen 518055,
Health Sciences Centre, 2075
0 5874.
ng), byang@sri.utoronto.ca
vier B.V.crucial roles in regulating tumor proliferation, apoptosis, angiogenesis,
and metastasis [5–7].
Although miRNAs are very small, they are highly conserved from
plants to mammals [8]. In plants, most miRNAs cleave mRNA targets,
which require perfect or nearly perfect matching of entire miRNAs to
their target sequences [3,9]. Since plants have evolved to adapt to
harsh environmental stimuli and are evolutionally diversiﬁed, many
miRNA families have a narrow phylogenetic distribution in terms of
their miRNA sequences and corresponding targets due to the require-
ment of the matching characteristic [10]. Thus, it is harder to predict/
identify miRNAs in plants than in animals, since plant miRNAs are less
conserved across different species. In contrast, it is more proﬁcient to
predict miRNA targets in plants than in animals, as it is relatively sim-
pler to ﬁnd long target sequences perfectly matching with the miRNA
sequences.
In animals,mostmiRNAsmediate translational repression by perfect
or nearly perfect matching of the 2–7 nucleotide “seed region” within
their targets [11]. The requirement for animal miRNA complementarity
is less restrictive than in plants [9,12], but less restrictive targeting can
still play important roles in repression of protein translation [13,14].
This may have placed less evolutionary selective pressure on animal
miRNAs, and as a consequence, animal miRNAs are highly conserved
3273F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285across species. In addition, the evolution selection also placed less pres-
sure on the targets, because smaller fragments of complementaritywith
miRNA seed regions are needed. Thismay also allowmiRNAs to respond
to environmental stresses effectively [15,16]. The resulting fact is that
eachmiRNA is found to potentially target a great number of mRNAs, be-
cause of reduced evolutionary pressures on animal mRNAs as miRNA
targets. This has formed the basis for computational prediction of
miRNA targets [17–19], and has been a great tool for researchers in the
identiﬁcation of miRNA targets, although false positive rates are high
[20]. Using this approach, we have identiﬁed many miRNA targets that
are conserved across different species. For example, many targets share
identical seed binding regions, including Sufu, Fus-1, and vimentin
targeting by miR-378a-5p [21,22], integrin-beta8 and the Large Tumor
Suppressor Homology 2 (LATS2) targeting bymiR-93 [23,24], hyaluronan
synthase 2 (HAS2) targeting by let-7 [25], ALK4 andMMP11 targeting by
miR-98 [26], GalNT7 and vimentin targeting by miR-17 [27], and PTPN9
and PTPRF targeting by miR-24 [28]. However, it is not clear whether
miRNA targets can be species-speciﬁc.
In this study, we demonstrated that although the coding sequences
and the 3′UTR of ﬁbronectin 1 were highly conserved across 20 species
(by bioinformatics analysis) they contained some potential binding
sites for 5 miRNAs in the rodent group but not in any other species.
One of them, potentially targeted by miR-378a-5p (also named miR-
378 or miR-378*), possessed the perfect matching seed sequence for
the miRNA. We then demonstrated that this rodent-speciﬁc targeting
was of biological consequence—mediating cell proliferation,migration,
invasion, and tumor growth.
2. Materials and methods
2.1. Generation of constructs and transgenic mice
A miRNA construct expressing miR-378a as well as a control con-
struct were developed by our lab previously [21,29]. In brief, the pre-
miRNA fragment of miR-378awas ligated into amammalian expression
vector BluGFP that contained a Bluescript backbone and a CMV promot-
er driving miR-378a expression. The precursor miR-378a can then be
processed to produce miR-378 (also named miR-378* or miR-378a-
5p) and miR-422b (also named miR-378 or miR-378a-3p). The control
plasmid was the same except that the pre-miR-378a sequence was re-
placed with a non-related sequence (5′atacagtactgtgataactgaagtttttggaa
aagctttagttattaa), serving as a mock control.
To repress endogenous miR-378a expression and function, we gen-
erated a construct that produced RNA transcripts to play two functions.
(1) Interfere with normal processing of the target precursor miR-378a,
which interrupts the normal process of miR-378a resulting in produc-
tion of imperfect truncated miR-378a. (2) Bind and arrest the function
of endogenous mature miR-378a-5p, which were those processed
through the normal miRNA biogenesis pathway, namely the miR-378a-
5p. The RNA transcript contained a long fragment to interact with sixteen
miRNAs. This formed a large complex and thereby arrested the functions
of the original mature miR-378a-5p and the imperfect miR-378a-5p. The
construct was named miR-Pirate378a, meaning microRNA-interacting
RNA—Producing imperfect RNA and tangling endogenous miR-378a (miR-
Pirate). The miR-Pirate378a transcript could bind and block miR-378a-
5p function.
A luciferase reporter vector (pMir-Report, Ambion) was used to gen-
erate the luciferase constructs. A fragment of the 3′UTR of mouse ﬁbro-
nectin which contained the predicted miR-378a-5p target site was
cloned by RT-PCR using primers mus-FN1-N3′SacI (5′ggg gagctc acaa
gtgtctctctaccaaggtc) and mus-FN-R378-MluI (5′cc acgcgt cacacagccaca
ggccatg), digested with SacI and MluI. The fragment was inserted into
SacI- and MluI-digested pMir-Report luciferase vector to obtain the lucif-
erase construct Luc-FN−378. A mutant construct Luc-FN−378-mut which
contained ﬁve nucleotide mutations at the predicted binding site was
also generated. It was generated by using primers mus-FN1-N3′SacI andmus-FN-R378-MluI-mut (5′cc acgcgt cacacagccacaggccatgaggtgac) in a
PCR, followed by cloning as above.
Transgenic mice expressing miR-Pirate378a was developed as re-
ported [29]. Brieﬂy, the transgene was released from the plasmid by di-
gestion with Bg1II and StuI, and microinjected into the male pronuclei
of CD-1 mouse zygotes. Injected embryos were implanted into the ovi-
ducts of pseudopregnant recipient females using a standard protocol
approved by the Animal Care Committee at Sunnybrook Research Insti-
tute, Ontario, Canada. Transgenic founder lines were maintained by
backcrossing with CD-1 F1 mice and genotyping was performed on
tail or ear DNA using primers complementary to the CMV promoter. In
the miR-Pirate378a transgenic mice, we consistently measured mature
miR-378a-5p levels as compared with the wildtype mice to ensure that
the transgene was functioning by down-regulating endogenous miR-
378a-5p.2.2. Cell proliferation assay
Mouse breast cancer cells 4T1 were stably transfected with miR-
378a,miR-Pirate378a and the control vector that contained a small frag-
ment of non-related insert serving as a negative control. The stably
transfected cells were seeded onto 6-well dishes in Dulbecco'smodiﬁed
Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and
maintained at 37 °C overnight. After overnight culture, the culture medi-
umwas removed and the cellswerewashedwith PBS, followedby cultur-
ing in DMEM containing either 2.5 or 10% FBS. Cells were harvested daily
and stained by trypan blue for quantiﬁcation by hemocytometer.2.3. Cell migration
The miR-378a, miR-Pirate378a- and vector-transfected 4T1 cells
were seeded onto 6-well dishes in 10% FBS/DMEM medium and
maintained at 37 °C until they reached a 95% conﬂuence. After treat-
ment with 200 μg/mL of mitomycin C for 2 h, the monolayer was
wounded by a sterile 200 μL pipette tip to create a cell-free path. Culture
mediumwas removed and the samples were washed with PBS, follow-
ed by culturing in 5% FBS/DMEM medium. The distances between two
sides of the wound were measured immediately and again at 24 and
48 h. The values were subject to statistical analysis.2.4. Cell invasion
The miR-378a, miR-Pirate378a and vector-transfected 4T1 cells
were loaded into serum-free medium inside the transwell inserts that
had been placed in a 24-well plate and pre-coated with 100 μL of
Matrigel (diluted at 1:10). Medium supplemented with 10% FBS was
added to the bottom of the wells. Cells were incubated at 37 °C and
were allowed to invade and migrate through the Matrigel onto the
membrane pores of the inserts. After 48 h, the upper Matrigel layer
and cells were removed, and the cells on the surface of the lower side
of the membrane were ﬁxed and stained. Cells that migrated onto the
lower surface were quantiﬁed from representative areas.2.5. Real-Time PCR
For mature miRNA analysis, total RNA was extracted from 1 × 106
cells or approximately 0.05 g tissue with the mirVana miRNA Isolation
Kit (Ambion) according to the manufacturer's instructions. cDNA was
synthesized using 1 μg RNA. Successive PCR was performed by
QuantiMir-RT Kit using 1 μL cDNA as a template (Qiagen, miScript Re-
verse Transcription Kit, cat#218060; miScript SYBR Green PCR Kit,
cat#218073). The primers used as controls for real-time PCR were
Human-U6RNAf and Human-U6RNAr as described [30].
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Protein lysates were subject to SDS-PAGE–Western blot assay as de-
scribed [31]. In brief, cell lysates were collected from the cultures or
extracted from frozen tissues and subject to SDS-PAGE electrophoresis
on 10% separating gel with a 4% stacking gel. The buffer system was
made up of 1× TG (Tris–glycine buffer, Amresco product) containing
1% SDS. The proteins separated on SDS-PAGE were transferred onto ni-
trocellulose membranes (Bio-Rad) in 1× TG buffer containing 20%Table 1
FN1 conservative miRNA across all 20 species. There are 12 miRNAs that can potentially target
Cricetulus griseus, Homo sapiens,Macaca mulatta, Ovis aries, Pan troglodytes, Rattus norvegicus, G
YesYesYesYesYesmiR–429–3p 
YesYesYesYesYesmiR–320–3p 
YesYesYesYesmiR–200b–3p 
YesYesYesYesmiR–196b–5p 
YesYesYesYesmiR–196a–5p 
YesYesYesmiR–187–3p 
YesYesYesYesYesmiR–185–5p 
YesYesYesYesmiR–181a–5p 
YesYesYesmiR–146b–5p 
YesYesYesmiR–139–3p 
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YeUAAUACUGUCUGGUAAUGCCGU miR–429–3p 
YeAAAAGCUGGGUUGAGAGGGCGA miR–320–3p 
YeUAAUACUGCCUGGUAAUGAUGA miR–200b–3p 
YeUAGGUAGUUUCCUGUUGUUGGG miR–196b–5p 
YeUAGGUAGUUUCAUGUUGUUGGG miR–196a–5p 
YeUCGUGUCUUGUGUUGCAGCCGG miR–187–3p 
UGGAGAGAAAGGCAGUUCCUGA miR–185–5p 
YeAACAUUCAACGCUGUCGGUGAGU miR–181a–5p 
UGAGAACUGAAUUCCAUAGGCU miR–146b–5p 
YeUGGAGACGCGGCCCUGUUGGAG miR–139–3p 
YeUUCACAGUGGCUAAGUUCUGC miR–27b–3p 
YeUUCACAGUGGCUAAGUUCCGC miR–27a–3p 
oaSequences from mmumiRNA
Spmethanol. The membrane was then blocked in TBST (10 mM Tris–Cl,
pH 8.0, 150 mM NaCl, 0.05% Tween 20) containing 5% skim milk pow-
der (TBSTM) for 1 h while being gently shaken at room temperature.
The membrane was then incubated at 4 °C overnight with primary
antibodies. The membranes were washed with TBST (6 × 10 min) and
incubated at room temperature with secondary anti-mouse or anti-
rabbit antibody conjugated to horseradish peroxidase in TBSTM. After
washing as above, the bound antibodies were visualized with the Chemi-
luminescent HRPAntibody Detection Kit (HyGLO, Denville Scientiﬁc Inc.).ﬁbronectin of most of the 20 species includingMus musculus, Bos taurus, Callithrix jacchus,
allus gallus, Oryzias latipes, and Xenopus tropicalis.
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Table 2
MiRNAs specially target rodent FN. FivemiRNAswere found to be able to potentially target exclusively FN ofMusmusculus, Cricetulus griseus, and Rattus norvegicus, which all belong to the
rodent family. Among these ﬁve miRNAs, only miRNA-378a-5p exhibits a perfect seed region match with the rodent FN1 (lower panel).
CricetulusgriseusRattusnorvegicusMusmusculus
Mus musculus FN1, NM_010233
Cricetulus griseus FN1, XM_003509268.1
Rattus norvegicus FN1, NM_019143
3´
5´
5´
3´
5´
3´
5´
3´
3´
5´
3´
5´
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4T1 cells were cultured in 12-well tissue culture plates at a density of
1 × 105 cells per well in DMEM containing 10% FBS. The cultures were
maintained at 37 °C for 24 h, followed by co-transfecting the ﬁbronectin
luciferase reporter construct (Luc-FN−378, 100 ng per well) or the mu-
tantﬁbronectin luciferase reporter construct (Luc-FN−378-mut) together
with miR-378a-5p mimics (800 ng per well, equal to 60 nM, fromA
B
Fig. 1.MiR-378a-5p species-speciﬁcally target rodent FN1. (A) Since human FN1 3′UTR is one of
5p binding sites of both human andmouse FN 3′UTR. The potential miR-378a-5p target site of m
different species. Note that the miR-378a-5p binding seed region is conserved in rodent specieGenePharma, Shanghai, China) using Lipofectamine 2000 in 500 μL
serum-free DMEM medium. Each transfection mixture also contained
10 ng pRL-Renilla Luciferase Control Reporter Vectors per well, which
served as an internal control to normalize the value of the ﬁreﬂy lucifer-
ase activities. A negative control construct (G3R), which contained a
non-related sequence ligated to a luciferase reporter, was also
transfected with miR-378a-5p mimic at the same ratio. All reactions
were set in triplicate. Six hours after the transfection, the cells wereC
the sequences showing high homologywith rodent FN1 3′UTR, we aligned themiR-378a-
ouse is highlightedwith a box. (B) Alignment ofmiR-378a-5p potential target sites across
s. (C) Analysis of consanguinity for 20 species involved in this study.
3276 F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285changed to fresh DMEM containing 10% FBS and incubated for 48 h. The
cells were then collected and luciferase activities were determined using
Dual-Luciferase® Reporter Assay System (Promega, Nepean, ON, Canada).A B
miR-Pirate378
-actin
vector
FN1
miR-378
-actin
vector
FN1
E
C
*
D
Fig. 2. Fibronectin is a direct target of miR-378a-5p and exerts effect on cell proliferation. (A) Ce
Western blot probed with anti-ﬁbronectin antibody. Fibronectin expression increased in the m
was cloned and linked to a luciferase reporter vector. The miR-378a-5p potential target site w
and a luciferase reporter construct, which was engineered with a fragment of the ﬁbronectin 3
As a negative control, the luciferase reporter construct was engineered with a non-related
transfected with miR-385-5p mimic at 0, 100, 300, 600, and 900 ng/mL (M-0, M-100, M-300,
P-900, respectively). The effects of miR-378a-5p mimic or miR-378a plasmid appeared to be
cultured with 2.5% FBS. Cell numbers were determined at 0, 1, 2, 3, 4, and 5 days. The miR-Pira
miR-378a-5p mimic or a control oligo for proliferation assay. miR-378a-5p treatment decreaseBrieﬂy, after removing growth media and rinsed with PBS, the cultures
were lysed in 1× Passive Lysis Buffer (150 μL per well). The culture plates
were gently shaken at room temperature for 15 min. 100 μL of luciferaseluciferase coding sequence
FN 3’UTRxxx
*
** **
*
**
F
ll lysate frommiR-378a-, miR-Pirate378a-, or vector-transfected 4T1 cells was analyzed on
iR-Pirate378a-transfection cells but decreased in the miR-378a cells. (B) The 3′UTR of FN
as mutated as indicated (red color). (C) 4T1 cells were co-transfected with miR-378a-5p
′UTR harboring the target sequence of miR-378a-5p (Luc-FN) or a mutant (Luc-FN-mut).
fragment of cDNA (G3R). Asterisk indicates signiﬁcant difference. (D) Luc-FN was co-
M-600, and M-900, respectively) or miR-378a plasmid at 600 and 900 ng/mL (P-600 and
dose-dependent. (E) The vector-, miR-378a-, and miR-Pirate378a-transfected cells were
te378a cells proliferated faster than the control cells. (F) 4T1 cells were also treated with
d cell proliferation.
3277F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285assay Buffer II was dispensed into each luminometer tube. 20 μL of cell ly-
sate was transferred to each tube and mixed. Fireﬂy luciferase activity
was determined using a luminometer (Berthold, Germany). 100 μL of
Stop &Glo®Reagentwas dispensed into the luminometer tube and Renilla
luciferase activitywasmeasured. The experimentalﬁreﬂy luciferase report-
er gene was normalized by dividing the Renilla luciferase activity by the
ﬁreﬂy luciferase activity. Relative luciferase activity was evaluated by com-
paring the luciferase activity of ﬁbronectin luciferase reporter construct orA
C
vector miR-Pirate378miR-378
E
vector4T1
Fig. 3. Effect of ﬁbronectin on cell migration, invasion, andmorphogenesis. (A) Cells were grow
Cells were photographed at 0 and 48 h. The distances between the wounding center and the f
miR-Pirate378a migrated faster, while the cells transfected with miR-378a migrated slower t
control oligo. Treatment with miR-378a-5p mimic decreased cell migration. (C) Cell invasion w
after ﬁxation and Coomassie blue staining. Invasion was quantiﬁed in ﬁve randomly selected ﬁ
control cells invaded through the Matrigel and membrane pores and spread on the underside o
mentwithmiR-378a-5pmimic also decreased cell invasion. (E) 4T1 cells transfectedwithmiR-P
examined on the second day. Transfection with miR-Pirate378a enhanced cell adhesion and cemutant ﬁbronectin luciferase reporter construct with negative control con-
struct. Each experiment was repeated three times.
2.8. Tumorigenicity assay
Tumorigenesis was performed as described previously [32]. Brieﬂy,
six-week-old miR-Pirate378a transgenic and wildtype CD-1 mice were
injected subcutaneously with 4T1 cells (5 × 105 cells in 150 μLMatrigelmiR-Pirate378
D
B
n to conﬂuence andwounded by scraping to create wounds and to test the repair process.
ront of the migrating cells were measured for statistic analysis. The cells transfected with
han the control cells (n = 10). (B) 4T1 cells were treated with miR-378a-5p mimic or a
as examined using Matrigel-coated transwell chambers. Cell invasion was photographed
elds. More miR-Pirate378a-transfected cells, but less miR-378a-transfected cells than the
f the membrane after two days (left, n = 5). Typical photos are shown (right). (D) Treat-
irate378a or the vectorwere cultured inmedium containing 10% FBS. Cellmorphologywas
ll aggregation.
3278 F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285permouse). 12 days after the injection, themicewere sacriﬁced and tu-
mors were removed. Tumor volume (V) was estimated using a caliper
by measuring the length (L) and width (W), where V = (L × W2) / 2.
As well, six-week-old wildtype BALB/c mice were injected subcutane-
ously with the miR-Pirate378a- and vector-transfected 4T1 cells
(5 × 105 cells in 150 μLMatrigel permouse). Twoweeks after injection,
tumors were removed and tumor volume was estimated as above.
2.9. Immunohistochemistry analysis
Tumors were freshly ﬁxed in 10% neutral buffered formalin
overnight, immersed in 70% ethanol, embedded in parafﬁn, and sec-
tioned by a microtome (Leica RM2255). Sections (4 μm thickness)
were deparafﬁnized in xylene twice for 5 min each and rehydrated byA
B
C
D
E
F
Fig. 4. Endogenousﬁbronectinmediates anti-miR-378a enhanced cellmigration and invasion in 4T
oligo followed byWestern blot analysis. Fibronectin expressionwas down-regulated by siRNA. (B)
with ﬁbronectin siRNAmigrated slower than the control cells. (C) siRNA- or control oligo-transfec
invasive than the control cells. (D) Rescue experiment was performed by transfecting ﬁbronecti
analysis conﬁrmed decrease in ﬁbronectin expression by siRNA transfection. (E) SiRNA- or vector-
anti-miR-378a induced migration (n = 10). (F) The cells were also subject to invasion assay. FNplacing the slides in 100% ethanol, 3 min each time for three times,
followed by washing twice in dH2O, 5 min each. The slides were
brought to a pressure cooker in 10 mM sodium citrate buffer (pH 6.0)
and thenmaintained at a sub-boiling temperature for 10 min tounmask
antigenic epitope. The slides were allowed to cool down for 30 min. En-
dogenous peroxidase activity was blocked by incubating the sections in
3% H2O2 solution in methanol at 4 °C for 20 min. The sections were
rinsed in TBS twice, 5 min each time. Non-speciﬁc reactions with cellu-
lar proteinswere blockedwith 10% goat serum at room temperature for
30 min. The slides were then incubated in a humidiﬁed chamber at 4 °C
overnight with primary antibody solution (primary antibody in TBS
containing 10% goat serum and 1% BSA at recommended antibody dilu-
ent), followed by washing three times in TBS, 5 min each. The slides
were then incubated with biotinylated secondary antibody which1 cells. (A) 4T1 cellswere transiently transfectedwith siRNA targetingﬁbronectin or a control
siRNA- or control oligo-transfected 4T1 cellswere subject tomigration assay. 4T1 cells treated
ted 4T1 cells were subject to invasion assay. 4T1 cells treatedwith ﬁbronectin siRNAwas less
n siRNA into the miR-Pirate378a 4T1 cells which expressed high levels of FN. Western blot
transfectedmiR-Pirate378a 4T1 cells were subject tomigration assay. FN siRNA could reverse
siRNA reversed miR-Pirate378a induced invasion (n = 5).
3279F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285was diluted in TBST followingmanufacturer's recommendation at 37 °C
for 45 min. ABC reagent (Vectastain Elite ABC Kit, Vector Lab) was pre-
pared according to the manufacturer's instructions and added to the
sections followed by incubation at 37 °C for 45 min. After washed for
three times in TBS, 5 min each, DAB (Peroxidase Substrate Kit, Vector
Lab) was added to each section and the staining wasmonitored closely.
As soon as the sections developed (turned brown), the slides was im-
mersed in dH2O followed by counterstaining in Mayer's Hematoxylin.
After dehydration in 95% ethanol twice and then xylene twice,
the sections were mounted with coverslips. Quantiﬁcation for the ﬁ-
bronectin staining was performed by ImageJ software. The ﬁnal
results were presented as percentages of positive area for ﬁbronec-
tin staining in the randomly selected ﬁelds after subtracting the
background.
2.10. Statistical analysis
The results (mean values ± SD) of all the experiments were subject
to statistical analysis by t-test. The level of signiﬁcance was set at
p b 0.05 (*) and p b 0.01 (**).
3. Results
3.1. Analysis of miRNA targeting ﬁbronectin
It has been reported that miRNAs display organ-speciﬁc, disease-
speciﬁc, even species-speciﬁc expression, and are involved in biologicalA B
DC
-actin
Fig. 5. Endogenousﬁbronectinmediates cellmigration and invasion inU87 cells. (A)Western bl
(B) U87 cells were treated with siRNA targeting ﬁbronectin. Treatment with siRNAs decrease
(D) Treatment with siRNAs displayed little effect on cell proliferation.processes ranging from metabolism to apoptosis to development. In
particular, the species-speciﬁc manner in which miRNA can target pro-
tein expression remains unclear, with implications in both species evo-
lution and disease development.We compared the ﬁbronectin 3′UTR of
20 species in order to analyze miRNAs that could potentially target this
site and found that the 3′UTRs of ﬁbronectin were highly conserved
across all species (Supplementary Fig. S1). We then performed miRNA
targeting analysis and found that 12miRNAs could conservatively target
most ﬁbronectin with perfect complementarity to the seed regions in
these species (Table 1). Since these 12 miRNAs had not been reported
in some species, the sequences of Mus musculus for these 12 miRNAs
were used to predict potential targets of ﬁbronectin by these 12miRNAs
(Table 1, yellow background).
Interestingly, we found ﬁve miRNAs that could potentially target all
3′UTR of FNs fromM. musculus, Cricetulus griseus, and Rattus norvegicus,
all ofwhich belonged to the rodent family (Table 2). The potential target
sites for these ﬁve miRNAs in the rodent family were listed. Among
these ﬁve miRNAs, only miRNA-378-5p showed a conservative 7-
nucleotide “seed sequence” which could perfectly match the 3′UTRs of
the rodent FN1 (Table 2, lower).
We aligned the 3′UTRs of mouse and human FN1. Although the ho-
mology was relatively high in many areas, the potential miR-378a-5p
target sites were less homologous (Fig. 1A). The human FN1 3′UTR
had several extra nucleotides in the potential miR-378a-5p binding
seed region, inhibiting themiR-378a-5p binding activity. To have a bet-
ter view of the miR-378a-5p binding sites across all species, we aligned
the conservative potential binding sequence in theﬁbronectin 3′UTRs ofcontrol
FN siRNA1
FN siRNA2
FN siRNA3
ot analysis showed that 4T1 cells expressed higher levels of ﬁbronectin (FN) thanU87 cells.
d cell migration. (C) Treatment with siRNA targeting ﬁbronectin inhibited cell invasion.
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Therewere three nucleotides (indicated in red) found in rodent FN1 but
not in the other species, conﬁrming the species-speciﬁc targeting of
miR-378a-5p to rodent ﬁbronectin. Analysis of consanguinity showed
that the rodent species had less genetic relationship with the other spe-
cies (Fig. 1C).
3.2. Effect of ﬁbronectin on cell proliferation targeted by miR-378a-5p
To examine biological relevance with the bioinformatics results, we
transfected themouse breast cancer cell line 4T1 and human glioblasto-
ma cell line U87 with miR-378a expression construct and the construct
namedmiR-Pirate378a, which could induce degradation and functional
arrest of endogenous miR-378a-5p. This construct was generated and
reported recently [33] and it is known that expression of miR-378a-5p
induced tumor growth and angiogenesis [21]. 4T1 cells were originallyB
C
A
50 µm
Fig. 6. Tumor growth promoted bymiR-Pirate378a. (A) The control- andmiR-Pirate378a-transf
injection.Mice injectedwithmiR-Pirate378a-transfected cells developed larger tumor compare
formed by the miR-Pirate378a-transfected cells. (C) Tumor derived from both miR-Pirate378a-
examine ﬁbronectin expression. Fibronectin expression was higher in the miR-Pirate378a de
expression of CD34 was detected in the miR-Pirate378a group of tumors compared with the
detected in the miR-Pirate378a group of tumors compared with the control. Typical photos areestablished by Aslakson and Miller [34] and used as a breast carcinoma
and metastasis model [35,36]. Real-time PCR analysis indicated that
miR-378a-5p expression was higher in the miR-378a-transfected 4T1
cells than cells transfected with a control vector, the GFP plasmid con-
taining a small fragment of non-related sequence (Supplementary
Fig. S2A). In contrast, cells transfected with miR-Pirate378a produced
lower levels of miR-378a-5p than cells transfectedwith the control vec-
tor. Western blot analysis showed that ﬁbronectin expression was
repressed by miR-378a transfection but up-regulated by miR-
Pirate378a transfection, conﬁrming the targeting of ﬁbronectin 3′UTR
bymiR-378a-5p inmouse cells (Fig. 2A). Real-time PCR analysis indicated
that themRNA levels inﬁbronectinwere not affected by transfectionwith
miR-378a or miR-Pirate378a (Supplementary Fig. S2B), suggesting regu-
lation at the post-transcriptional level. Nevertheless, ﬁbronectin levels
were not affected bymiR-378a transfection nor bymiR-Pirate378a trans-
fection in U87 cells, conﬁrming that human ﬁbronectin was not targetedD
E
50 µm
50 µm
ected 4T1 cells were injected into CD1mice. Tumor sizesweremeasured 2 weeks after the
dwith the control cells (n = 6). (B) Expression of ﬁbronectinwas promoted in the tumors
and vector-transfected cells were sectioned and stained with anti-ﬁbronectin antibody to
rived tumors than that of the controls. Typical photos are shown (lower). (D) Increased
control. Typical photos are shown (right). (E) Signiﬁcantly more Ki67 positive cells were
shown (right).
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Fus-1 is a target ofmiR-378a-5p inU87 cells [21].We analyzed Fus-1 level
in the 4T1 cells transfected with miR-378a, miR-Pirate378a, or a vector
control, but detected little difference (Supplementary Fig. S2D), sug-
gesting that Fus-1 might not be targeted by miR-378a-5p in 4T1 cells.
To validate the targeting of ﬁbronectin by miR-378a-5p in mouse,
we cloned the 3′UTR ofmouse ﬁbronectin and ligated it into a luciferase
reporter vector, producing Luc-FN−378 (Fig. 2B). The miR-378a-5p po-
tential target site was mutated as indicated in red. The sequences of the
constructs were provided in Supplementary Fig. S2E. 4T1 cells were
co-transfected with the miR-378a-5p mimic and the luciferase reporter
construct containing ﬁbronectin 3′UTR harboring the target sequence of
miR-378a-5p (Luc-FN−378) or the mutant (Luc-FN−378-mut). We found
thatmiR-378a-5p transfection signiﬁcantly decreased luciferase activities
in the cells transfected with the luciferase reporter construct containing
the ﬁbronectin 3′UTR as compared with the cells transfected with the
control construct containing an un-related sequence (Fig. 2C). The repres-
sive activitieswere reversedwhen themiR-378a-5p binding sitewasmu-
tated. The luciferase construct was also co-transfected with miR-378a-5p
mimic or miR-378a plasmid with different concentrations, which con-
ﬁrmed reduction in luciferase activities (Fig. 2D).
We then examined the effects of miR-378a-5p targeting ﬁbronectin
on mediating cell activities. 4T1 cells were transfected with miR-378a,
miR-Pirate378a, and the control vector and cultured in medium con-
taining 2.5% or 10% FBS. We observed that cells transfected with miR-
378a displayed decreased proliferation but cells transfected with miR-
Pirate378a displayed increased rates of proliferation as compared with
the control when the cells were cultured in medium containing 2.5%
FBS (Fig. 2E), but the effect was shielded by 10% FBS (Supplementary
Fig. S3A). Decreased cell proliferation was also observed when 4T1
cells were transfected with miR-378a-5p mimic (Fig. 2F).
3.3. Effect of ﬁbronectin on cell migration and invasion targeted by
miR-378a-5p
To testwhether or not ﬁbronectin could exertmore extensive effects
on 4T1 cells, we performedmigration assay using cells transfected with
miR-378a, miR-Pirate378a, or the control vector and found that cells
transfected with miR-378a migrated slower while cells transfected
with miR-Pirate378a migrated faster than those transfected with the
control vector (Fig. 3A, Supplementary Fig. S3B). Decreased cell migra-
tion was also observed when the cells were transfected with miR-
378a-5p mimic (Fig. 3B).
We assessed the potential effects of ﬁbronectin on 4T1 cell invasion
using transwell invasion assay. The miR-378a-, miR-Pirate378a- and
vector-transfected 4T1 cells were cultured in 100 μL serum-free medi-
um in Matrigel-coated transwell inserts. Transfection with miR-378a
was found less invasive while transfection with miR-Pirate378a was
found more invasive than the control cells (Fig. 3C). Decreased cell mi-
gration was also observed when the cells were transfected with miR-
378a-5p mimic (Fig. 3D). Examination of cell morphology indicated
that cells transfected with miR-378a displayed greater activity in adhe-
sion and spreading, while cells transfected with miR-Pirate378a tended
to migrate together (Supplementary Fig. S4A). Transfection with miR-
Pirate378a induced formation of large complex of the cells (Fig. 3E).
3.4. Conﬁrmation of the effect of endogenous ﬁbronectin on cell migration
and invasion
Since we observed that miR-Pirate378a-transfected cells, which
exhibited high levels of ﬁbronectin expression, had increased cellmobil-
ity,more experimentswere conducted to demonstrate that the effects of
miR-Pirate378a weremediated by ﬁbronectin.We silenced endogenous
ﬁbronectin expression by delivering three siRNA targeting ﬁbronectin
into the 4T1 cells. Decreased ﬁbronectin expression was conﬁrmed by
Western blot (Fig. 4A). Silencing of ﬁbronectin expression inhibited4T1 cell migration (Fig. 4B, Supplementary Fig. S4B) and invasion
(Fig. 4C, Supplementary Fig. S4C), indicating that endogenous ﬁbronec-
tin could enhance cell mobility. We then performed experiments
by transfecting the miR-Pirate378a-transfected cells with ﬁbronectin
siRNAs. Western blot analysis conﬁrmed silencing of ﬁbronectin in the
siRNA-transfected cells (Fig. 4D). Elimination of ﬁbronectin expression
reversed the stimulatory effects of miR-Pirate378a on cell migration
(Fig. 4E, Supplementary Fig. S5A) and invasion (Fig. 4F, Supplementary
Fig. S5B).We tested the effects of ﬁbronectin in another cell line U87. Al-
though U87 cells were found to express lower levels of ﬁbronectin
(Fig. 5A) than 4T1 cells, silencing endogenous ﬁbronectin also reduced
cell migration (Fig. 5B) and invasion (Fig. 5C). However, silencing ﬁbro-
nectin showed little effect on cell proliferation (Fig. 5D).
3.5. miR-Pirate378a increases ﬁbronectin expression and promotes 4T1 cell
tumor formation
Based on theproliferation results obtained from in vitro experiments
above, we speculated that miR-Pirate378a could regulate ﬁbronectin
expression thus affecting tumor formation in vivo. The miR-
Pirate378a- and vector-transfected 4T1 cells were injected into BALB/c
regular mice. Two weeks after injection, tumor growth was examined
in both groups: themicewere sacriﬁced and tumors were removed. As-
sessment of tumor sizes indicated that the miR-Pirate378a-tranfected
4T1 cells formed larger tumors than the vector-transfected cells
(Fig. 6A).
Western blot and immunohistochemistry analysis were performed
on tumors derived from both the miR-Pirate378a- and vector-
transfected 4T1 cells. Western blot analysis showed that ﬁbronectin
expression was higher in the tumors formed by the miR-Pirate378a-
tranfected 4T1 cells than those formed by the control cells (Fig. 6B).
Immunohistochemistry analysis further conﬁrmed enhanced ﬁbronec-
tin expression in both the surrounding and central areas of tumors
formed by the miR-Pirate378a-transfected cells compared with those
formed by the control cells (Fig. 6C). Furthermore, CD34 levels were
higher in the tumors formed by the miR-Pirate378a-transfected 4T1
cells, conﬁrming increased angiogenesis (Fig. 6D). Additionally, Ki67
levels were higher in the miR-Pirate378a tumors, corresponding to
the increased tumor sizes (Fig. 6E). Taken together, both in vitro and
in vivo studies demonstrated that the miR-Pirate378a transfection
could induce higher levels of ﬁbronectin expression in 4T1 cells and
thus promote tumor formation.
3.6. Tumor formation was inhibited in miR-Pirate378a transgenic mice
with high ﬁbronectin expression
Since the biological characteristic of tumorswas determined both by
the stromal microenvironment and the tumor cells, we next sought to
test whether high expression of exogenous ﬁbronectin could affect
tumor growth. We used the miR-Pirate378a transgenic mice [33], as a
model to test the effects of miR-378a-5p on tumor growth. Real-time
PCR analysis conﬁrmed reduced level of miR-378a-5p expression in
the transgenic mice (Fig. 7A). Wildtype and the miR-Pirate378a trans-
genic micewere injected with 4T1 cells for tumor growth assay. We de-
tected a signiﬁcant difference in tumor sizes two weeks after the
injection: the miR-Pirate378a transgenic mice had much smaller tu-
mors than the wildtype mice (Fig. 7B).
To further conﬁrm that miR-Pirate378a could regulate ﬁbronec-
tin expression, liver samples were harvested and subject to Western
blot analysis where enhanced ﬁbronectin expression was found in
transgenic mice compared with wildtype mice (Fig. 7C). In addition,
tumors were sectioned for immunohistochemistry analysis, using anti-
ﬁbronectin, anti-Ki67, and anti-CD34 antibodies. Although ﬁbronectin
levels varied in different parts of the tumors, it was generally lower in
the wildtype mice than in the miR-Pirate378a transgenic mice (Fig. 7D).
In the wildtype mice, ﬁbronectin expression was approximately equal
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3283F. Liu et al. / Biochimica et Biophysica Acta 1833 (2013) 3272–3285between tumor tissues and stromal tissues. In the miR-Pirate378a mice,
ﬁbronectin levels were higher in the stromal tissues than in the tumor
tissues, and the borders between the tumors and the stromal tissues
were distinguishable. These results suggested that in the miR-
Pirate378a transgenic mice, the background of ﬁbronectin expression
levels was high, tumor growth rates were suppressed due to a high ﬁbro-
nectin microenvironment.
Expression of Ki67, a proliferating marker, was examined. The Ki67
positive cells were detected not only in the tumor areas but also in the
stromal areas of the wildtype mice, suggesting a mix of tumor cells with
the stromal cells (Fig. 7E). On the other hand, in themiR-Pirate378a trans-
genic mice, the Ki67 positive cells were mainly detected in the tumor
areas, but much fewer in the stromal areas, conﬁrming a clear border be-
tween the tumor and the stromal tissues. This suggested that the tumor
cells were restricted by the stromal tissues that expressed high levels of
ﬁbronectin. Furthermore, CD34 levels were found distributed not only
in the tumors but also in the stromal tissues of the wildtypemice, further
conﬁrming mixture of tumor cells and stromal cells (Fig. 7F). In the miR-
Pirate378a transgenic mice, the CD34 positive blood vessels were mainly
found in the tumors but not in the stromal tissues, conﬁrming restriction
of tumor growth by the stromal tissues.
4. Discussion
The key features in animal miRNA targeting are the required
complementarity to 5′ seed region ofmiRNAs and the evolutionary con-
servation. As most functional miRNA-target interactions are conserved
across species, this has been exploited in target identiﬁcation. Re-
searchers have taken advantage of these features and successfully pre-
dicted a great number of miRNA targets [2–4,13,17], many of which
have been validated experimentally [2,37,38]. However, some miRNA/
mRNA interactions may not adhere to canonical seed complementarity
and some miRNA target sites may not be conserved across all species.
For example, let-7 can target human oncogene HMGA2 but not the
HMGA2 orthologs in worms and ﬂies [39,40]. Computational analysis
showed that miR-96 could target progesterone receptor in rhesusmon-
key and human but not in rodents, whereas miR-375 targeting proges-
terone receptor was rhesus monkey-speciﬁc, which were conﬁrmed by
luciferase assays [16]. This species-speciﬁc targeting adds another layer
of miRNA regulation to the already complicated miRNA functional
network.
Most algorithms have assumed that high levels of complementarity
are particularly important in the seed region, typically nucleotides 2–8
of the miRNAs [14,41]. Target sites with perfect complementarity to
the seed region of miRNAs are typically called canonical sites. It has
been reported that some targets with imperfect seed match, can still
be repressed by the miRNAs [42,43]. Targets that lack perfect 5′ seed
matching but have contiguous base pair matching in the center of the
miRNA can still serve as a target of the miRNA [44]. Thus, there seems
to be a deviation to the requirement of complementarity at the seed
regions. The less stringent requirement for miRNA targeting has created
complex network of miRNA–mRNA cross-talk [45,46]. In fact, the
conserved target sites only represent a small proportion of miRNA
targeting; a great number of potential miRNA target sites are not con-
served. Whether or not the potential non-conserved target sitesFig. 7. Tumor formation was inhibited in the miR-Pirate378a-transgenic mice. (A) Total RNA is
miR-378a by real-time PCR. MaturemiR-378a-5p expression decreased in the transgenic mice c
miR-Pirate378a transgenicmice. Themicewere sacriﬁced and tumor sizesweremeasured on da
thewild typemice (upper, n = 5). Typical tumors are shown (lower). (C) Liver lysates harveste
higher in tissues from miR-Pirate378a transgenic mice than those from the wild type mice. (D
mice, ﬁbronectin appeared equally distributing in tumor (T) tissues and stromal (S) tissues. I
miR-Pirate378a transgenicmice, ﬁbronectin levels were higher in the stromal tissues than in th
(lower). (E) Expression of Ki67 was examined. The proliferating cells were distributed in the tu
tumor areas of themiR-Pirate378a transgenic mice. Typical photos are shown (lower). (F) Simil
in the tumor areas and stromal areas of the wildtype mice, while they were mainly detected inmediate miRNA repression of gene expression has to be tested experi-
mentally. Even in the conserved target sites, many are false-positive.
For example, the target site of miR-378a-5p in FUS-1 is conserved in
human and mouse. However, we have previously found that miR-
378a-5p repressed FUS-1 expression in human cells [21], but could
not detected repression inmouse cells in this report. Themechanism as-
sociated with this deviation is not known. This appears to be cell type
speciﬁc for regulation of gene expression by miRNAs.
Usingmost of the target prediction algorithms available, miRNA tar-
gets that are not highly conserved will be excluded. While some of the
predicted sites may correspond to true targets, these can often be ex-
cluded due to lack of conservation across species. Since evolution is a
complex process, it is conceivable that some miRNA targets can reside
in a speciﬁc group of species. In this study, we report that miR-378a-
5p only targeted rodent ﬁbronectin speciﬁcally. By bioinformatics anal-
ysis, there was no potential miR-378a-5p target detected in ﬁbronectin
of the other species. Although ﬁbronectin was found highly conserved
across 20 species that were available in the database, the miR-378a-5p
target site, on the other hand, was conserved only in rodent ﬁbronectin.
In particular, none of the other species possessed a conserved sequence
complementary to the seed region of miR-378a-5p.
miR-378a-5pwas originally reported to be expressed in a number of
cancer cell lines [47] and has been reported to be involved in the expres-
sion of vascular endothelial growth factor [38]. To understand the func-
tions of miR-378a-5p, we previously generated a miR-378a expression
construct and expressed it in human glioblastoma cell line U87. We
demonstrated that cells transfected with miR-378a survived longer
and formed larger tumors and blood vessels than the control [21]. Sub-
sequently, the expression and function of miR-378a have been exten-
sively studied [48–51]. This miRNA is reported to play roles in both
the cardiovascular system and cancer development [48–52] and has
been proposed as a biomarker for renal cell carcinoma [53]. Ectopic ex-
pression of miR-378a enhances cell differentiation [54]. It facilitates
ovarian estradiol production by targeting aromatase [55] and promoted
tissue invasion by targeting Nodal [56]. With the well-established func-
tions,miR-378a-5p, aside from the perfectmatching of its seed region to
rodent ﬁbronectin, is an ideal candidate to validate the effect of the
rodent-speciﬁc targeting.
To examine whether this rodent-speciﬁc targeting was of biological
signiﬁcance, we expressed the miR-378a-5p expression construct and
miR-Pirate378a construct inmouse breast cancer cells 4T1.We detected
the functions for miR-378a-5p, which were different from what we de-
tected previously [21]. In this study, we found that up-regulation of ﬁ-
bronectin by suppressing endogenous miR-378a-5p activity increased
cell proliferation, migration, invasion and tumor growth. Silencing en-
dogenous ﬁbronectin decreased cellmigration and invasion. It appeared
that the major target of miR-378a-5p in mouse was ﬁbronectin, while
ﬁbronectin in human cells was not a target of miR-378a-5p. This
explained the different functions of miR-378a-5p between mouse and
human cells.
Fibronectin is an extracellular glycoprotein which can bind to
integrins and mediate cell proliferation, adhesion, and tissue develop-
ment [57–59], and can alsomodulate stem cell migration and differentia-
tion [60,61]. In addition, ﬁbronectin can regulate tissue morphogenesis
[62] and plays a role in liver regeneration [63]. Fibronectin can also induceolated from heart of transgenic and wild type mice was subject to measuring the levels of
omparedwith thewild typemice. (B) 4T1 cells were injected into wild type CD1mice and
y 12. The tumorswere smaller in themiR-Pirate378a transgenicmice than those formed in
d from two pairs ofmicewere subject toWestern blot analysis. Fibronectin expressionwas
) Tumors were sectioned and subject to immunohistochemistry analysis. In the wildtype
n addition, there was no clear border between tumor tissues and stromal tissues. In the
e tumor tissues (upper). There were clear borders between tumors and the stromal tissues
mor areas and stromal areas of the wildtype mice, while they were mainly detected in the
ar patterns of CD34 expressionwere observed (upper). The blood vesselswere distributed
the tumor areas of the miR-Pirate378a transgenic mice (lower).
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phorylation of ﬁbroblast growth factor receptor-1 [64], cell adhesion
[65], and wound repair [66]. In our study, we found that up-regulation
ofﬁbronectin enhanced cellmigration and invasion,while silencingﬁbro-
nectin levels inhibited cellmigration and invasion. It suggested that ﬁbro-
nectin played a major role in mediating miR-378a-5p functions.
One interesting observation was the results obtained in the tumor
growth assay. We found that cells expressing ﬁbronectin (4T1 cells
transfectedwithmiR-Pirate378a) formed larger tumors than the controls.
In the contrast, tumors grew slower in the miR-Pirate378a transgenic
mice than in the wildtype mice. This was because the miR-Pirate378a
transgenic mice would produce higher levels of ﬁbronectin than the
wildtype mice. As a consequence, the stromal ﬁbronectin would inhibit
tumor cell growth. It is known that integrin–ﬁbronectin interactions
and the ﬁbronectin matrix assembly (FNMA) are crucial to establish
strong bonds between cells. The FNMA can prevent dispersal of cells
from a tumor-like mass. Indeed cell spreading ability is inversely propor-
tional to the formation of FNMA [67]. In the presence of FNMA, cells re-
main in clusters. Blocking FNMA formation restores the cell spreading
capacity [67]. This may explain why ﬁbronectin expressed by the tumor
cells and ﬁbronectin expressed in the stromal tissues played different
functions in mediating cell activities.
Our study reported that miRNA miR-378a-5p could specially target
rodent ﬁbronectin. This targeting mediated extensive biological func-
tions in vitro and in vivo. We also demonstrated that ﬁbronectin
expressed by the tumor cells and ﬁbronectin expressed by the stromal
tissues exerted different effects in mediating cell activities and tumor
growth. It is anticipated that more and more species-speciﬁc miRNA
targeting will be uncovered in future studies.
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